المؤلفون: Leman R; Laboratoire de Biologie et Génétique du Cancer, Centre François Baclesse, Caen, France.; Inserm U1245, UNIROUEN, FHU-G4 génomique, Normandie Université, Rouen, France.; UNICAEN, Normandie Université, Caen, France., Parfait B; Service de Génétique et Biologie Moléculaires, APHP, HUPC, Hôpital Cochin, Paris, France., Vidaud D; Service de Génétique et Biologie Moléculaires, APHP, HUPC, Hôpital Cochin, Paris, France., Girodon E; Service de Génétique et Biologie Moléculaires, APHP, HUPC, Hôpital Cochin, Paris, France., Pacot L; Service de Génétique et Biologie Moléculaires, APHP, HUPC, Hôpital Cochin, Paris, France., Le Gac G; Inserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, Brest, France., Ka C; Inserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, Brest, France., Ferec C; Inserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, Brest, France., Fichou Y; Inserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, Brest, France., Quesnelle C; Laboratoire de Biologie et Génétique du Cancer, Centre François Baclesse, Caen, France., Aucouturier C; Laboratoire de Biologie et Génétique du Cancer, Centre François Baclesse, Caen, France.; Inserm U1245, UNIROUEN, FHU-G4 génomique, Normandie Université, Rouen, France., Muller E; Laboratoire de Biologie et Génétique du Cancer, Centre François Baclesse, Caen, France., Vaur D; Laboratoire de Biologie et Génétique du Cancer, Centre François Baclesse, Caen, France.; Inserm U1245, UNIROUEN, FHU-G4 génomique, Normandie Université, Rouen, France., Castera L; Laboratoire de Biologie et Génétique du Cancer, Centre François Baclesse, Caen, France.; Inserm U1245, UNIROUEN, FHU-G4 génomique, Normandie Université, Rouen, France., Boulouard F; Laboratoire de Biologie et Génétique du Cancer, Centre François Baclesse, Caen, France.; Inserm U1245, UNIROUEN, FHU-G4 génomique, Normandie Université, Rouen, France., Ricou A; Laboratoire de Biologie et Génétique du Cancer, Centre François Baclesse, Caen, France.; Inserm U1245, UNIROUEN, FHU-G4 génomique, Normandie Université, Rouen, France., Tubeuf H; Inserm U1245, UNIROUEN, FHU-G4 génomique, Normandie Université, Rouen, France.; Integrative Biosoftware, Rouen, France., Soukarieh O; Inserm U1245, UNIROUEN, FHU-G4 génomique, Normandie Université, Rouen, France., Gaildrat P; Inserm U1245, UNIROUEN, FHU-G4 génomique, Normandie Université, Rouen, France., Riant F; Laboratoire de Génétique, AP-HP, GH Saint-Louis-Lariboisière-Fernand Widal, Paris, France., Guillaud-Bataille M; Département de Biopathologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Caputo SM; Department of Genetics, Institut Curie, Paris Sciences Lettres Research University, Paris, France., Caux-Moncoutier V; Department of Genetics, Institut Curie, Paris Sciences Lettres Research University, Paris, France., Boutry-Kryza N; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon, Lyon, France., Bonnet-Dorion F; Departement de Biopathologie Unité de Génétique Constitutionnelle, Institut Bergonie-INSERM U1218, Bordeaux, France., Schultz I; Laboratoire d'Oncogénétique, Centre Paul Strauss, Strasbourg, France., Rossing M; Centre for Genomic Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Quenez O; Inserm U1245, UNIROUEN, FHU-G4 génomique, Normandie Université, Rouen, France., Goldenberg L; Inserm U1245, UNIROUEN, FHU-G4 génomique, Normandie Université, Rouen, France., Harter V; Department of Biostatistics, Baclesse Unicancer Center, Caen, France., Parsons MT; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Spurdle AB; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Frébourg T; Inserm U1245, UNIROUEN, FHU-G4 génomique, Normandie Université, Rouen, France.; Department of genetics, Rouen University Hospital, Rouen, France., Martins A; Inserm U1245, UNIROUEN, FHU-G4 génomique, Normandie Université, Rouen, France., Houdayer C; Inserm U1245, UNIROUEN, FHU-G4 génomique, Normandie Université, Rouen, France.; Department of genetics, Rouen University Hospital, Rouen, France., Krieger S; Laboratoire de Biologie et Génétique du Cancer, Centre François Baclesse, Caen, France.; Inserm U1245, UNIROUEN, FHU-G4 génomique, Normandie Université, Rouen, France.; UNICAEN, Normandie Université, Caen, France.

المصدر: Human mutation [Hum Mutat] 2022 Dec; Vol. 43 (12), pp. 2308-2323. Date of Electronic Publication: 2022 Nov 20.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 9215429 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-1004 (Electronic) Linking ISSN: 10597794 NLM ISO Abbreviation: Hum Mutat Subsets: MEDLINE

مواضيع طبية MeSH: RNA Splicing*/genetics , RNA Splice Sites*/genetics, Humans ; Bayes Theorem ; Exons/genetics ; Machine Learning ; Introns/genetics

المؤلفون: Thomassen M; Department of Clinical Genetics, Odense University Hospital, Odence C, Denmark., Mesman RLS; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands., Hansen TVO; Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Menendez M; Hereditary Cancer Program, Catalan Institute of Oncology, ONCOBELL-IDIBELL-IDTP, CIBERONC, Hospitalet de Llobregat, Spain., Rossing M; Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Esteban-Sánchez A; Molecular Oncology Laboratory, CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain., Tudini E; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Törngren T; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Parsons MT; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Pedersen IS; Molecular Diagnostics, Aalborg University Hospital, Aalborg, Denmark.; Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark., Teo SH; Breast Cancer Research Programme, Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.; Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Kruse TA; Department of Clinical Genetics, Odense University Hospital, Odence C, Denmark., Møller P; Department of Tumour Biology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Borg Å; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Jensen UB; Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark., Christensen LL; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark., Singer CF; Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Muhr D; Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Santamarina M; Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, Spain.; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid, Spain., Brandao R; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, the Netherlands., Andresen BS; Department of Biochemistry and Molecular Biology and the Villum Center for Bioanalytical Sciences, University of Southern Denmark, Odense, Denmark., Feng BJ; Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, USA., Canson D; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Richardson ME; Ambry Genetics, Aliso Viejo, California, USA., Karam R; Ambry Genetics, Aliso Viejo, California, USA., Pesaran T; Ambry Genetics, Aliso Viejo, California, USA., LaDuca H; Ambry Genetics, Aliso Viejo, California, USA., Conner BR; Ambry Genetics, Aliso Viejo, California, USA., Abualkheir N; Ambry Genetics, Aliso Viejo, California, USA., Hoang L; Ambry Genetics, Aliso Viejo, California, USA., Calléja FMGR; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands., Andrews L; Hereditary Cancer Clinic, Nelune Comprehensive Cancer Care Centre, Sydney, New South Wales, Australia., James PA; Parkville Familial Cancer Centre, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Bunyan D; Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK., Hamblett A; Middlesex Health Shoreline Cancer Center, Westbrook, Connecticut, USA., Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Goldgar DE; Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, USA., Walker LC; Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand., Engel C; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany., Claes KBM; Centre for Medical Genetics, Ghent University, Gent, Belgium., Macháčková E; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic., Baralle D; Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, UK., Viel A; Division of Functional Onco-genomics and Genetics, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy., Wappenschmidt B; Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Lazaro C; Hereditary Cancer Program, Catalan Institute of Oncology, ONCOBELL-IDIBELL-IDTP, CIBERONC, Hospitalet de Llobregat, Spain., Vega A; Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, Spain.; Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Madrid, Spain., Vreeswijk MPG; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands., de la Hoya M; Molecular Oncology Laboratory, CIBERONC, Hospital Clinico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain., Spurdle AB; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

مؤلفون مشاركون: ENIGMA Consortium; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

المصدر: Human mutation [Hum Mutat] 2022 Dec; Vol. 43 (12), pp. 1921-1944. Date of Electronic Publication: 2022 Oct 23.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 9215429 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-1004 (Electronic) Linking ISSN: 10597794 NLM ISO Abbreviation: Hum Mutat Subsets: MEDLINE

مواضيع طبية MeSH: Genes, BRCA2* , RNA Splice Sites*, Animals ; Humans ; Mice ; Alternative Splicing ; BRCA2 Protein/genetics ; BRCA2 Protein/metabolism ; RNA Splicing ; RNA, Messenger/genetics ; RNA, Messenger/metabolism

المؤلفون: Høxbroe Michaelsen S; Department of ORL, Head & Neck Surgery and Audiology, Odense University Hospital, Odense, Denmark., Ornstrup MJ; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark., Poulsen MM; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark., Bennedbaek FN; Department of Endocrinology, Herlev and Gentofte University Hospital, Herlev, Denmark., Gaustadnes M; Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark., Rossing M; Center for Genomic Medicine, Copenhagen University Hospital, Copenhagen, Denmark., Darling P; Department of ORL, Head & Neck Surgery and Audiology, Odense University Hospital, Odense, Denmark., Vestergaard P; Department of Clinical Medicine and Endocrinology, Aalborg University Hospital, Aalborg, Denmark.; Steno Diabetes Center North Jutland, Aalborg University Hospital, Aalborg, Denmark., Mathiesen JS; Department of ORL, Head & Neck Surgery and Audiology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.

المصدر: Journal of surgical oncology [J Surg Oncol] 2019 May; Vol. 119 (6), pp. 687-693. Date of Electronic Publication: 2019 Jan 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0222643 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9098 (Electronic) Linking ISSN: 00224790 NLM ISO Abbreviation: J Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Heterozygote* , Mutation*, Genetic Predisposition to Disease/*epidemiology , Proto-Oncogene Proteins c-ret/*genetics, Adolescent ; Adult ; Aged ; Aged, 80 and over ; Carcinoma, Medullary/genetics ; Child ; Cohort Studies ; Denmark/epidemiology ; Follow-Up Studies ; Humans ; Middle Aged ; Multiple Endocrine Neoplasia Type 2a/genetics ; Pheochromocytoma/genetics ; Thyroid Neoplasms/genetics ; Young Adult

المؤلفون: Burke LJ; School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia., Sevcik J; School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia.; Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic., Gambino G; School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia.; Section of Molecular Genetics, Department of Laboratory Medicine, University Hospital of Pisa, Pisa, Italy., Tudini E; School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia.; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia., Mucaki EJ; University of Western Ontario, Department of Biochemistry, Schulich School of Medicine and Dentistry, London, Ontario, Canada., Shirley BC; CytoGnomix Inc., London, Ontario, Canada., Whiley P; School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia.; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia., Parsons MT; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia., De Leeneer K; Center for Medical Genetics, Ghent University Hospital, and Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium., Gutiérrez-Enríquez S; Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Santamariña M; Fundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica-USC, CIBERER, IDIS, Santiago de Compostela, Spain., Caputo SM; Service de Génétique, Department de Biologie des Tumeurs, Institut Curie, Paris, France., Santana Dos Santos E; Service de Génétique, Department de Biologie des Tumeurs, Institut Curie, Paris, France.; Department of oncology, Center for Translational Oncology, Cancer Institute of the State of São Paulo - ICESP, São Paulo, Brazil.; A.C.Camargo Cancer Center, São Paulo, Brazil., Soukupova J; Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic., Janatova M; Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic., Zemankova P; Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic., Lhotova K; Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic., Stolarova L; Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic., Borecka M; Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, Prague, Czech Republic., Moles-Fernández A; Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Manoukian S; Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy., Bonanni B; Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy., Edwards SL; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia., Blok MJ; Department of Clinical Genetics, Maastricht University Medical Centre, Maastricht, The Netherlands., van Overeem Hansen T; Center for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Rossing M; Center for Genomic Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Diez O; Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Area of Clinical and Molecular Genetics, University Hospital Vall d'Hebron (UHVH), Barcelona, Spain., Vega A; Fundación Pública Galega de Medicina Xenómica-SERGAS, Grupo de Medicina Xenómica-USC, CIBERER, IDIS, Santiago de Compostela, Spain., Claes KBM; Center for Medical Genetics, Ghent University Hospital, and Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium., Goldgar DE; Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Rouleau E; Gustave Roussy, Villejuif, France., Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Peterlongo P; IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy., Rogan PK; University of Western Ontario, Department of Biochemistry, Schulich School of Medicine and Dentistry, London, Ontario, Canada.; CytoGnomix Inc., London, Ontario, Canada., Caligo M; Section of Molecular Genetics, Department of Laboratory Medicine, University Hospital of Pisa, Pisa, Italy., Spurdle AB; Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia., Brown MA; School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia.

مؤلفون مشاركون: ENIGMA Consortium; School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Australia.

المصدر: Human mutation [Hum Mutat] 2018 Dec; Vol. 39 (12), pp. 2025-2039. Date of Electronic Publication: 2018 Sep 24.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 9215429 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-1004 (Electronic) Linking ISSN: 10597794 NLM ISO Abbreviation: Hum Mutat Subsets: MEDLINE

مواضيع طبية MeSH: Germ-Line Mutation* , Promoter Regions, Genetic*, BRCA1 Protein/*genetics , BRCA2 Protein/*genetics , Breast Neoplasms/*genetics, 5' Untranslated Regions ; Age of Onset ; BRCA1 Protein/chemistry ; BRCA1 Protein/metabolism ; BRCA2 Protein/chemistry ; BRCA2 Protein/metabolism ; CCAAT-Binding Factor/metabolism ; Cell Line, Tumor ; Female ; Genetic Predisposition to Disease ; Humans ; MCF-7 Cells ; PAX5 Transcription Factor/metabolism ; Protein Binding

SCR Disease Name: Breast Cancer, Familial

المؤلفون: Lambe M; Department of Medical Epidemiology, Karolinska Institutet, Stockholm, Sweden. Mats.Lambe@mep.ki.se, Rossing MA, Wuu J, Hsieh C

المصدر: International journal of cancer [Int J Cancer] 2001 Sep; Vol. 93 (6), pp. 907-10.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print Cited Medium: Print ISSN: 0020-7136 (Print) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Sexual Partners*, Breast Neoplasms/*epidemiology , Breast Neoplasms/*immunology, Adult ; Age Factors ; Aged ; Fathers ; Female ; Humans ; Middle Aged ; Multivariate Analysis ; Odds Ratio ; Parity ; Risk

المؤلفون: Satia JA; Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA. jsatia@fhcrc.org, Patterson RE, Herrero R, Jin F, Dai Q, King IB, Chen C, Kristal AR, Prentice RL, Rossing MA

المصدر: International journal of cancer [Int J Cancer] 1999 Jul 02; Vol. 82 (1), pp. 28-32.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print Cited Medium: Print ISSN: 0020-7136 (Print) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Diet*, Neoplasms/*etiology, Adult ; Aged ; Ascorbic Acid/blood ; Biomarkers ; China ; Costa Rica ; Fatty Acids/blood ; Female ; Humans ; Male ; Middle Aged ; Risk ; United States

المؤلفون: Rossing MA; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98104., Vaughan TL, McKnight B

المصدر: International journal of cancer [Int J Cancer] 1989 Oct 15; Vol. 44 (4), pp. 593-7.

نوع المنشور: Comparative Study; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print Cited Medium: Print ISSN: 0020-7136 (Print) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Diet Surveys* , Nutrition Surveys*, Pharyngeal Neoplasms/*epidemiology, Adult ; Aged ; Alcohol Drinking ; Case-Control Studies ; Female ; Humans ; Logistic Models ; Male ; Middle Aged ; Pharyngeal Neoplasms/prevention & control ; Risk Factors ; Smoking/epidemiology ; Vitamins/administration & dosage ; Washington